G.R. No. 209271 - International Service for the Acquisition of Agri-Biotech Applications, Inc. vs. Greenpeace Southeast Asia

Case Summary (G.R. No. 209271)

Factual Background

The controversy concerned multi‑locational field trials in the Philippines of a genetically engineered eggplant known as "Bt talong," in which Bt—crystal toxin genes from Bacillus thuringiensis—was introduced to express the Cry1Ac protein toxic to certain lepidopteran larvae. The project involved UPLB and partners including ISAAA, MAHYCO (India), Cornell University and ABSPII/USAID. UPLB secured BPI biosafety permits after contained experiments completed in 2007–2009. Field trials commenced at approved sites in Kabacan (North Cotabato), Sta. Maria (Pangasinan), Pili (Camarines Sur), Bago Oshiro (Davao City) and Bay (Laguna). Local governments and civil society groups raised alarms about public consultation, environmental assessment, possible contamination, non‑target effects, development of resistance, and absence of independent long‑term safety studies. Greenpeace, MASIPAG and individual respondents filed a petition for writ of kalikasan and continuing mandamus seeking a TEPO to halt field trials and various writs to compel regulatory review, public participation, environmental assessment, and cessation of Bt talong trials.

Regulatory Framework

The case unfolded against a layered regulatory backdrop. The Philippines developed biosafety guidelines beginning with the NCBP and the 1991 and 1998 Philippine Biosafety Guidelines. In 2002 the DA promulgated DAO 08-2002 to govern importation and release into the environment of plants derived from modern biotechnology and to vest BPI with authority over field tests. The Philippines ratified the Cartagena Protocol on Biosafety, and in 2006 the President issued EO No. 514, establishing the National Biosafety Framework (NBF) and enlarging the role and composition of the National Committee on Biosafety of the Philippines (NCBP). EO 514 expressly required that precaution guide biosafety decisions and that concerned agencies determine whether the Philippine Environmental Impact Statement System (PEISS) should apply to biosafety decisions. The Rules of Procedure for Environmental Cases incorporate the Precautionary Principle in Rule 20, instructing courts to apply it when full scientific certainty is lacking.

Procedural History

After the writ of kalikasan issued by the Supreme Court, the Court referred the case to the Court of Appeals for reception of returns, hearing of evidence, and judgment. The CA accepted jurisdiction, held a merits hearing using a concurrent expert or "hot‑tub" method, and on May 17, 2013 granted the petitioners’ reliefs by directing respondents to permanently cease Bt talong field trials and to protect and restore the environment. The CA applied the precautionary principle and concluded that existing biosafety regulations were insufficient. Motions for reconsideration were denied on September 20, 2013. ISAAA, the DA agencies, UPLB, UPLBFI and others sought review in consolidated petitions to the Supreme Court.

The Parties’ Principal Contentions

Petitioners (ISAAA, EMB/BPI/FPA, UP, UPLBFI, Crop Life, intervenors) advanced several interlocking arguments: the petition was moot or academic because permits had expired and trials were terminated; the CA exceeded its authority and raised political questions by directing regulatory policy changes; respondents failed to exhaust administrative remedies and primary jurisdiction lay with DA/BPI and other agencies; the precautionary principle was misapplied and unsupported by scientific evidence on record; the CA deprived petitioners of due process and unduly interfered with academic freedom; and DA procedures under DAO 08-2002 sufficiently safeguarded biosafety. EMB/BPI/FPA emphasized that risk assessments were conducted, independent Scientific and Technical Review Panel reports recommended permits, public information sheets and consultative meetings were provided, and that field trials do not equate to commercial release. Petitioners attacked the credibility and admissibility of studies relied upon by respondents, including the controversial Seralini paper.

Respondents (Greenpeace, MASIPAG and individuals) argued that the field trials violated citizens’ constitutional rights to health and a balanced ecology because (inter alia) no ECC under PD 1151/PD 1586 had been secured, the biosafety review and public consultation were inadequate under the NBF, and independent, comprehensive risk and socio‑economic assessments had not been done. They invoked the Precautionary Principle, submitted a compendium of scientific references alleging potential human‑health and environmental harms, and insisted that the existing regulatory framework left gaps in transparency, public participation and long‑term monitoring.

Expert Evidence and the "Hot‑Tub" Hearing

The CA convened a simultaneous expert hearing. Petitioners produced experts such as Dr. Reynaldo Ebora, Dr. Saturnina Halos and Dr. Peter Davies, who testified generally in favor of regulatory sufficiency and safety findings for Bt constructs, citing long histories of Bt use and large bodies of studies. Respondents presented Dr. Ben Malayang, Dr. Charito Medina and Dr. Tushar Chakraborty, who emphasized biodiversity sensitivity, uncertainties, potential non‑target and long‑term risks, and inadequacy of existing data. The CA confronted experts with the Seralini rat‑feeding study alleging tumorigenesis in rats fed Roundup‑treated GMO maize; that study had been widely criticized and later retracted and subsequently republished, creating further controversy. The hot‑tub produced divergent conclusions rather than consensus; the CA relied on testimony stressing uncertainty and risk to apply the precautionary principle.

Issues Presented to the Supreme Court

The Supreme Court identified and decided the principal issues: legal standing of Greenpeace, et al.; mootness and the "capable of repetition yet evading review" exception; exhaustion of administrative remedies and primary jurisdiction; applicability of the PEISS/EIS requirements to GMO field testing; whether respondents proved damage or a threat of damage to health or environment in two or more provinces; alleged unlawful omissions by public respondents in permit processing; and the correct application of the Precautionary Principle.

The Supreme Court’s Ruling and Disposition

The Supreme Court denied the consolidated petitions for relief from the CA decision but significantly modified the CA disposition. The Court ordered: (1) the conduct of the assailed Bt talong field testing permanently enjoined; (2) Department of Agriculture Administrative Order No. 08, series of 2002 declared NULL AND VOID; and (3) any application for contained use, field testing, propagation, commercialization and importation of genetically modified organisms is TEMPORARILY ENJOINED until a new administrative order is promulgated in accordance with law. No costs were awarded. The Court applied the 1987 Constitution and international obligations.

Legal Basis and Reasoning

The Court first confirmed respondents’ standing under the liberalized doctrine for environmental actions and A.M. No. 09‑6‑8‑SC and precedent such as Oposa v. Factoran. On mootness, the Court accepted the CA’s exercise of jurisdiction despite the termination of the immediate field trials. It found the case fell within the exceptions to mootness because the controversy was capable of repetition yet evading review and involved matters of paramount public interest.

On administrative remedies and primary jurisdiction, the Court recognized the normal rule that courts defer to administrative bodies but reiterated that the doctrines are not inflexible. It found that DAO 08‑2002 and other administrative mechanisms did not provide a plain, speedy and adequate remedy for the questions raised about national biosafety policy, public participation and EIA requirements; thus, judicial intervention was appropriate.

Turning to the substantive regulatory scheme, the Court focused on the National Biosafety Framework under EO No. 514, which required that biosafety decisions be guided by the precautionary approach, ensure transparent and participatory decision‑making, and determine the applicability of the PEISS to biosafety decisions. The Court found substantial lapses in operationalizing the NBF. It concluded that DAO 08‑2002 did not adequately implement EO 514’s public‑participation, transparency and EIA directives. In particular the Court accepted evidence that EMB had not consistently evaluated the applicability of the PEISS to these field trials and that DAO 08‑2002’s public‑participation mechanisms were deficient (posting of Public Information Sheets in limited venues, narrow opportunity to submit comments, applicant‑dominated Institutional Biosafety Committees and no adequate appeal mechanism for third‑party stakeholders).

Because the NBF requires that environmental assessments be done where appropriate, and because the release of living modified organisms raises scientific uncertainty and the potential for irreversible, seriatim harms to biodiversity and human health in a bi

Case Syllabus (G.R. No. 209271)

Parties and Procedural Posture

International Service for the Acquisition of Agri-Biotech Applications, Inc. (ISAAA) filed petition for review of the Court of Appeals decision that permanently enjoined Bt talong field trials.
Greenpeace Southeast Asia (Philippines), MASIPAG, and individual citizens filed the original petition for writ of kalikasan and writ of continuing mandamus seeking to stop Bt eggplant field trials.
The Environmental Management Bureau (EMB), Bureau of Plant Industry (BPI) and Fertilizer and Pesticide Authority (FPA) joined as petitioners challenging the Court of Appeals ruling.
Petitions were consolidated with related petitions in different G.R. numbers and the issues were heard en banc by the Supreme Court.
The reliefs sought below included a Temporary Environmental Protection Order, permanent cessation of field trials, orders to undergo Environmental Impact Statement (EIS) processes, and regulatory reforms of the biosafety framework.

Key Factual Allegations

The contested project was multi-locational field testing of an eggplant genetically engineered to express Cry1Ac (a Bt toxin) for resistance to fruit and shoot borer.
Field trials followed contained laboratory experiments completed in 2009 and biosafety permits issued by BPI in 2010 for sites in North Cotabato, Pangasinan, Camarines Sur, Davao City and Laguna.
Petitioners alleged lack of an Environmental Compliance Certificate (ECC) under PD No. 1151/PD 1586, inadequate public consultation, and insufficient independent peer-reviewed safety data.
Respondents alleged specific risks including cross-pollination, harm to non-target species, development of resistant pests, and long-term human health hazards evidenced by selected scientific studies.
Proponents asserted compliance with DAO 08-2002, reliance on NCBP and BPI risk assessments, and empirical experience with Bt crops showing no documented large-scale harm.

Regulatory and Legal Framework

DAO 08-2002 governed importation and field release of plants and plant products derived from modern biotechnology under the Department of Agriculture.
Executive Order No. 514 (National Biosafety Framework, NBF) established principles for biosafety, public participation and application of the precautionary principle consistent with the Cartagena Protocol.
Presidential Decrees PD No. 1151 and PD No. 1586 established the Philippine Environmental Impact Statement System and the ECC/CNC regime.
The Rules of Procedure for Environmental Cases incorporate the precautionary principle (Rule 20) and provide citizen standing mechanisms such as the writ of kalikasan and writ of continuing mandamus.

Issues Presented

Whether respondents had legal standing to file the petition for writ of kalikasan.
Whether the controversy was moot and academic given termination/expiration of field trials and biosafety permits.
Whether petitioners failed to exhaust administrative remedies and whether primary jurisdiction lies with regulatory agencies.
Whether DAO 08-2002 and procedural practices complied with the NBF, the Cartagena Protocol, and EIS requirements.
Whether the record showed damage or a threat of serious or irreversible harm to human health or the environment in two or more provinces.
Whether the precautionary principle was properly applied by the Court of Appeals.

Parties' Main Contentions

Petitioners (ISAAA, UPLB, UPLBFI, EMB/BPI/FPA) argued the Court of Appeals erred in granting the writ because the petition was moot, raised political questions, failed to exhaust administrative remedies, and improperly substituted judicial judgment for regulatory expertise.
Petitioners argued the proponents complied with DAO 08-2002, that field testing does not equate to commercialization, and that scientific evidence does not substantiate the alleged harms.
Respondents maintained they satisfied standing, that the project lacked an ECC, that public consultations were inadequate, and that scientific uncertainty and documented studies warranted application of the precautionary principle and injunctive relief.

Proceedings Below

The Supreme Court issued a writ of kalikasan and referred the case to the Court of Appeals for reception of evidence and judgment.
The Court of Appeals conducted a merits hearing using the concurrent-expert or “hot-tub” method and admitted testimony from multiple local and foreign scientific witnesses.
The Court of Appeals denied motions to intervene by some industry groups and rendered judgment granting the petition and permanently enjoining the Bt talong field trials on May 17, 2013.
The Court of Appeals de